Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation

Oncogene

Volumn 27, Issue 27, 2008, Pages 3789-3796

  Costoya, J A ^a,b   Hobbs, R M ^a,c   Pandolfi, P P ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle; Cyclin dependent kinases; PEST domains; POZ and Kr ppel type zinc finger domains; Transcriptional repression; Ubiquitination

Indexed keywords

CYCLIN DEPENDENT KINASE 2;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA ZINC FINGER GENE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASES; HAPLORHINI; HUMANS; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; PHOSPHORYLATION; REPRESSOR PROTEINS; TRANSFECTION; TRANSLOCATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; ZINC FINGERS;

EID: 45549091159     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.7     Document Type: Article

References (31)

1. Barna M, Hawe N, Niswander L, Pandolfi PP. (2000). Plzf regulates limb and axial skeletal patterning. Nat Genet 25: 166-172.
2. Barna M, Merghoub T, Costoya JA, Ruggero D, Branford M, Bergia A et al. (2002). Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell 3: 499-510.
3. Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J, Yamada KM. (2000). Current Protocols in Cell Biology. John Wiley: Cambridge.
4. Brissette JL, Kumar NM, Gilula NB, Dotto GP. (1991). The tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins. Mol Cell Biol 11: 5364-5371.
5. Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, Griswold MD et al. (2004). Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet 36: 647-652.
6. Chao TT, Chang CC, Shih HM. (2007). SUMO modification modulates the transrepression activity of PLZF. Biochem Biophys Res Commun 358: 475-482.
7. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY et al. (1993). Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12: 1161-1167.
8. Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R et al. (1995). Expressio n of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. Proc Natl Acad Sci USA 92: 2249-2253.
9. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M et al. (2004). Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 36: 653-659.
10. Costoya JA, Pandolfi PP. (2001). The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. Curr Opin Hematol 8: 212-217.
11. Deed RW, Hara E, Atherton GT, Peters G, Norton JD. (1997). Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation. Mol Cell Biol 17: 6815-6821.
12. Filipponi D, Hobbs RM, Ottolenghi S, Rossi P, Jannini EA, Pandolfi PP et al. (2007). Repressio n of kit expression by Plzf in germ cells. Mol Cell Biol 27: 6770-6781.
13. Guidez F, Howell L, Isalan M, Cebrat M, Alani RM, Ivins S et al. (2005). Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol 25: 5552-5566.
14. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y et al. (2004). Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431: 1002-1007.
15. Johnson TK, Schweppe RE, Septer J, Lewis RE. (1999). Phosphorylation of B-Myb regulates its transactivation potential and DNA binding. J Biol Chem 274: 36741-36749.
16. Kang SI, Chang WJ, Cho SG, Kim IY. (2003). Modificatio n of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity. J Biol Chem 278: 51479-51483.
17. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M et al. (1991). Human cyclin E a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228.
18. Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD. (1997). Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J Biol Chem 272: 22447-22455.
19. Malumbres M, Barbacid M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231.
20. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. (2003). Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol 163: 489-502.
21. Niu H, Ye BH, Dalla-Favera R. (1998). Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 12: 1953-1961.
22. Piazza F, Costoya JA, Merghoub T, Hobbs RM, Pandolfi PP. (2004). Disruption of PLZP in mice leads to increased T-lymphocyte proliferation cytokine production and altered hematopoietic stem cell homeostasis. Mol Cell Biol 24: 10456-10469.
23. Rechsteiner M, Rogers SW. (1996). PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271.
24. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J et al. (1995). Leukemia translocation gene PLZF is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86: 4544-4552.
25. Rogatsky I, Trowbridge JM, Garabedian MJ. (1999). Potentiatio n of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J Biol Chem 274: 22296-22302.
26. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price Jr E, Roberts RL et al. (2003). A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 22: 6471-6482.
27. Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S et al. (1998). The promyelocytic leukemia zinc finger protein affects myeloid cell growth differentiation and apoptosis. Mol Cell Biol 18: 5533-5545.
28. Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
29. Ubersax JA, Ferrell Jr JE. (2007). Mecha nisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 8: 530-541.
30. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S et al. (1999). Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18: 925-934.
31. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT et al. (2006). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518-522.